Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Last week patent highlights (11-05-09):
1. NF- kB Inhibitors And Uses Thereof - new class of imidazolines as 4-position esters with very potent anti-inflammatory as well as antimicrobial activity
2. M3 Muscarinic Acetylcholine Receptor Antagonists
3. 3,11 b-cis-Dihydrotetrabenazine for the Treatment of a Proliferative Disease or an Inflammatory Disease
4. Heterocyclic Compounds as MEK Inhibitors
5. Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
6. Methods of diagnosing and treating parp-mediated diseases
7. Carboxamide Compounds and Methods for Using The Same
8. TRICYCLIC OPIOID MODULATORS - The invention is directed to compounds of Formula useful as delta and mu opioid receptor modulators
9. Compounds Which Modulate The CB2 Receptor
10. Compound With Antimalarial Activity And Antimalarial Drug Containing The Same As Active Ingredient
11. INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1
12. Methylphenidate Derivatives and Uses of Them
13. Method of treating thermoregulatory disfunction with paroxetine
14. STRAIGHTFORWARD ENTRY TO 7-AZABICYCLO[2.2.1]HEPTANE-1-CARBONITRILES AND SUBSEQUENT SYNTHESIS OF EPIBATIDINE ANALOGUES
15. Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds
16. 1, 5-DIPHENYL-3-BENZYLAMINO-1, 5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS
17. Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
18. SUBSTITUTED 5- PHENYLAMINO- 1, 3, 4-OXADIAZOL-2-YLCARBONYLAMINO-4-PHENOXY-CYCLOHEXANE CARBOXYLIC ACID AS INHIBITORS OF ACETYL COENZYME A DIACYLGLYCEROL ACYLTRANSFERASE
19. 1, 3, 4-OXADIAZOL-2-ONES AS PPAR DELTA MODULATORS AND THEIR USE THEREOF
20. NIZATIDINE FORMULATIONS - Pharmaceutical formulations comprising nizatidine or salts thereof
21. ALPHA-AMINO ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME AS AN ACTIVE INGREDIENT
22. INHIBITORS OF CDC PHOSPHATASES - subject of the present invention is novel compounds comprising 2 or 3 benzothiazole-4 7-dione- or benzooxazole-4
23. NOVEL THIAZOLIDIN 4-ONE DERIVATIVES - pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders
24. PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROGENIC PAIN
25. ALPHA2B AND ALPHA2C AGONISTS - Described herein are compounds that can be useful as bioactive agents
26. Substituted Spiro-Compounds And The Use Thereof For Producing Medicaments
27. THERAPY FOR THE TREATMENT OF DISEASE - Disclosed herein are pharmaceutical compositions comprising various combinations of an antimuscarinic or an
28. COSMETIC COMPOSITION COMPRISING AN IMIDOPERCARBOXYLIC ACID DERIVATIVE AND A N-ACYLATED AMINO ACID ESTER
29. THERAPEUTIC ANTISENSE OLIGONUCLEOTIDE COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
30. Methods of diagnosis and treatment - method of diagnosing a disease in which an miRNA is expressed at a lower level comprises in a test sample obtained
31. Novel Tumour Suppressor - method of diagnosing cancer includes the steps of, in a sample obtained from a subject, determining the level or activity of
32. ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES
33. SCREENING METHOD - method of modulating Wnt signalling comprising modulating Trabid activity
34. PICORNAVIRUS AND USES THEREOF - The invention is directed to a a clade of newly isolated and identified picornaviruses associated with respiratory
35. PROTEIN TYROSINE PHOSPHATASE INHIBITORS - compositions and methods for binding and/or modulating enzymatic activity of human protein tyrosine
36. Compositions and Methods for Inhibiting Expression of XBP-1 Gene
37. USP47 INHIBTORS AND METHODS TO INDUCE APOPTOSIS
38. siRNA targeting inner centromere protein antigens (INCENP)
39. RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
40. DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
41. Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
42. Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
43. METHOD TO INDUCE NEOVASCULAR FORMATION AND TISSUE REGENERATION
44. THERAPEUTIC COMPOUNDS - Compounds having a structure STR00001 are disclosed herein
45. TAXANE DERIVATIVE COMPOSITION - stable, absolutely ethanol free composition of docetaxel that prevents alcoholic intoxication or anaphylactic shock
46. MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME
47. Compositions And Methods For Identifying Modulars Of TRPV2
48. 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
49. Alcanoic Acid Amides Substituted by Saturated O-Heterocycles
50. BIOFILM FORMATION INHIBITOR COMPOSITION - drug and a composition for inhibiting biofilm formation are provided
51. POLYMORPHIC FORMS OF LADOSTIGIL TARTRATE
52. Pharmaceutical Gallium Compositions and Methods
53. Pharmaceutical Gallium Compositions and Methods
54. Medicinal Compositions of Salts, Chelates and/or Free Acids of Alpha Hydroxyl Organic Acids and Related Processes and Methods
55. Fatty acid antimicrobial - The novel antimicrobial composition is disclosed including from about 60 to 95% of a lipophilic polar solvent such as
56. Method for Producing a Raw Oil from Mixtures of Micro-Organisms and Plants, Oil Produced According to Said Method and Specific Uses of the Thus Produced Oil and, Optionally, Additional Refined Oil
57. Phenyl acetic acid derivatives as inflammation modulators
58. STABLE PARENTERAL FORMULATIONS OF TIGECYCLINE
59. PREPARATION OF THE FORMAURINDICARBOXYLIC ACID BASE AND ITS DERIVATIONS AND USE
60. Injectable veterinary composition - comprising a fluorinated chloramphenicol or thiamphenicol derivative and a solvent system comprising an ether of 1
61. Method for Producing a Disinfecting Agent
62. NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
63. Enhanced biological potential of greater than 99% pure form of 1, 7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione over corresponding 95% pure form-therapeutic and agricultural applications thereof
64. CONDENSATION PRODUCTS, METHOD FOR THEIR PRODUCTION AND USE THEREOF IN MEDICAMENTS, AS DISINFECTANTS OR AS A TANNIN
65. USE OF ALLICIN AS PRESERVATIVE, AS DISINFECTANT, AS ANTIMICROBIAL OR AS BIOCIDAL AGENT
66. Sprayable Gel-Type Skin/Mucosa-Adhesive Preparation and Administration System Using the Preparation
67. Flavor and fragrance composition - with a cooling sensation effect comprising 1-ethanone represented by the formula
68. DOG PHEROMONE FORMULATION AND DELIVERY SYSTEM
69. TWO COMPONENT BONE CEMENT COMPOSITION FOR VERTEBROPLASTY
70. Sustained-Release Tablet Production Process
71. Benzocyclobutene based polymer formulations and methods for processing such formulations in oxidative environments
72. UV/EB Curable Biobased Coating for Flooring Application
73. RUBBER COMPOSITION FOR TREAD AND PNEUMATIC TIRE USING THE SAME
74. Process for Producing Particulate Resin - process for particulate-resin production from an aqueous solution containing resin particles by recovering the
75. COATING COMPOSITION - aqueous coating composition comprising a mixture of recycled rubber particles and particles at least one of glass or plastic
76. THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE THEREOF
77. System and method for the pre-treatment of rubber-modified asphalt cement, and emulsions thereof
78. HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYESTERS, THE PRODUCTION THEREOF AND THE USE OF THE SAME
79. PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION
80. Resin Composition Excellent in Flame Retardance
81. Flame Retardant Thermoplastic Resin Composition
82. HIGH CTI POLY(ARYLENE ETHER) COMPOSITION
83. SELF-LUBRICATING SURFACE COATING COMPOSITION
84. PIGMENT AND POLYMERIC MATERIALS MATTED THEREWITH
85. PROCESS OF RECYCLING PAINT SLUDGE AND COMPONENT MADE THEREOF
86. Thermoconductive Silicone Elastomer, Thermoconductive Silicone Elastomer Composition And Thermoconductive Medium
87. ULTRASOUND ASSISTED CONTINUOUS PROCESS FOR DISPERSION OF NANOFIBERS AND NANOTUBES IN POLYMERS
88. Articles Comprising Nonpolar Polyolefin and Polyurethane, and Methods for Their Preparation and Use
89. METHOD FOR THE PRODUCTION OF CO-EXTRUDATES COMPOSED OF POLYSTYRENE AND OF A CROSSLINKED POLYVINYLPYRROLIDONE WITH REDUCED RESIDUAL STYRENE MONOMER CONTENT
90. Alphatic polyester composition and method for producing the same
91. Viscosity Control for Reduced Fluorosurfactant Aqueous Fluoropolymer Dispersions by the Addition of Cationic Surfactants
92. Spin-on-Glass Anti-Reflective Coatings for Photolithography
93. PROCESS FOR PREPARING SILOXANE-BASED COMPOSITIONS AND DERIVATIVE COMPOSITIONS THEREOF
94. Vapor Grown Carbon Fiber, and Production Method and Use Thereof
95. Manufacturing process for liquid crystalline polymer
96. Method of Making Polybutylene Terephthalate and Compositions and Articles Comprising the Same
97. Starch containing formaldehyde-free thermoset binders for fiber products
98. Propylene-Based Polymer Composition for Adhesive Use and Laminate Thereof
99. Curable Composition Based On Polyurethane And On Block Copolymers, And Transparent Material Obtained From Said Composition
100. MOISTURE CURABLE POLYMER HAVING SiF GROUP, AND CURABLE COMPOSITION CONTAINING THE SAME
previous page next page
Archives
09-04-08 07-02-09 10-16-08 05-28-09 12-25-08 10-01-09 09-11-08 07-09-09 02-26-09 08-13-0911-20-08 07-30-09 12-18-08 09-10-09 11-27-08 04-16-09 06-11-09 01-08-09 05-14-09 11-06-08
08-27-09 09-24-09 10-15-09 06-18-09 09-17-09 03-26-09 01-15-09 10-30-08 06-25-09 12-04-08
10-08-09 08-06-09 02-19-09 06-04-09 10-23-08 02-12-09 04-23-09 09-25-08 05-21-09 01-29-09
03-05-09 12-11-08 03-19-09 04-30-09 01-01-09 10-22-09 10-29-09 07-23-09 07-16-09 05-07-09
02-05-09 03-12-09 10-02-08 04-09-09 09-03-09 08-20-09 04-02-09 10-09-08 11-13-08 01-22-09
08-28-08 09-18-08 08-21-08